Table 1 Characteristics of the COPD patients enrolled in the study
From: Deficiency of innate-like T lymphocytes in chronic obstructive pulmonary disease
Stable COPD cohort | AECOPD cohort | |
Age | 60.8 ± 8.99 | 64.9 ± 14.09 |
CAT | 21.8 ± 8.1 | 31.4 ± 5.87* |
CCQ | 28.1 ± 15.88 | 43.2 ± 9.041* |
FEV1 (% predicted) | 54.45 ± 12.34 | 41.8 ± 18.9 |
FEV1 (liter) | 1.612 ± 0.558 | 1.027 ± 0.4942 |
Tiffenau-index | 53.73 ± 7.129 | 47.43 ± 9.467 |
Treatments | ||
Inhaled steroids (Y/N) | 6/5 | 10/0 |
Long acting muscarinic agonist (LAMA) (Y/N) | 11/0 | 10/0 |
Long acting β agonist (LABA) (Y/N) | 8/3 | 10/0 |